Estimaciones de analistas de Wall Street para Quoin Pharmaceuticals, Ltd. (QNRX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-1.63 | ||
| 2026-08-14 | $-1.90 | $-1.83 | -3.8% |
| 2026-05-07 | $-1.77 | $-1.80 | +1.7% |
| 2026-03-26 | $-14.80 | $-6.42 | -130.5% |
| 2025-11-06 | $-6.71 | $-6.36 | -5.5% |
| 2025-08-07 | $-6.28 | $-6.83 | +8.1% |
| 2025-05-13 | $-6.50 | $-3.85 | -68.8% |
| 2025-03-13 | $-12.24 | $-0.50 | -2348.0% |
Ratios de valoración
| Precio / Valor contable | 3.52 |
| EV / EBITDA | -0.57 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | -$280000 | 0 | -$280000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $89130 | $104223 | $125720 | $227055 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$369130 | -$104223 | -$405720 | -$227055 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $8.3M | $5.9M | $8.3M | $45650 | $244155 | $1.6M | $2.7M | $3.3M | $3.6M | $9.8M |
| Generales y Administrativos | $8.0M | $4.2M | $8.0M | $1.5M | $1.4M | $4.5M | $6.6M | $6.1M | $5.9M | $6.5M |
| Gastos Operativos | $16.2M | $10.1M | $16.2M | $1.6M | $1.7M | $6.1M | $9.3M | $9.4M | $9.5M | $16.3M |
| Beneficio Operativo | $15.3M | $10.2M | $15.3M | -$1.6M | -$1.7M | -$6.1M | -$9.3M | -$9.4M | -$9.5M | -$16.3M |
| EBITDA | -$3.9M | -$7.8M | -$5.5M | -$1.5M | -$1.6M | -$20.3M | -$8.6M | -$8.6M | -$8.9M | -$15.7M |
| Gastos por Intereses | 0 | 0 | 0 | $412292 | $1.2M | $1.1M | $714081 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $15.3M | $10.2M | $15.3M | -$1.6M | -$2.1M | -$21.5M | -$9.4M | -$8.7M | -$9.0M | -$15.8M |
| Impuestos | $147942 | -$1.2M | -$161141 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $15.3M | $10.2M | $15.3M | -$1.6M | -$2.1M | -$21.5M | -$9.4M | -$8.7M | -$9.0M | -$15.8M |
| BPA | $-160847.00 | $-257489.00 | $-158862.00 | $-16307.00 | $-1290.96 | $-2490.26 | $-11.42 | $-11781.00 | $-2352.81 | $-10.63 |
| BPA Diluido | $-160847.00 | $-257489.00 | $-158862.00 | $-16307.00 | $-1290.96 | $-2490.26 | $-11.42 | $-11781.00 | $-2352.81 | $-10.63 |
| Acciones en Circulación (Diluidas) | $24 | $30 | $35 | $289 | $1634 | $8624 | $823706 | $735 | $3827 | $1.5M |
Precio
| Precio | $6.90 |
| Capitalización | $14M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CYCN · KTTA · NBY · PLRZ · PMCB · RADX · TCRT
Explorar sector: Healthcare · Biotechnology
Más secciones de QNRX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones